» Articles » PMID: 37047701

The Effect of CaV1.2 Inhibitor Nifedipine on Chondrogenic Differentiation of Human Bone Marrow or Menstrual Blood-Derived Mesenchymal Stem Cells and Chondrocytes

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Apr 13
PMID 37047701
Authors
Affiliations
Soon will be listed here.
Abstract

Cartilage is an avascular tissue and sensitive to mechanical trauma and/or age-related degenerative processes leading to the development of osteoarthritis (OA). Therefore, it is important to investigate the mesenchymal cell-based chondrogenic regenerating mechanisms and possible their regulation. The aim of this study was to investigate the role of intracellular calcium (iCa) and its regulation through voltage-operated calcium channels (VOCC) on chondrogenic differentiation of mesenchymal stem/stromal cells derived from human bone marrow (BMMSCs) and menstrual blood (MenSCs) in comparison to OA chondrocytes. The level of iCa was highest in chondrocytes, whereas iCa store capacity was biggest in MenSCs and they proliferated better as compared to other cells. The level of CaV1.2 channels was also highest in OA chondrocytes than in other cells. CaV1.2 antagonist nifedipine slightly suppressed iCa, Cav1.2 and the proliferation of all cells and affected iCa stores, particularly in BMMSCs. The expression of the CaV1.2 gene during 21 days of chondrogenic differentiation was highest in MenSCs, showing the weakest chondrogenic differentiation, which was stimulated by the nifedipine. The best chondrogenic differentiation potential showed BMMSCs ( and expression); however, purposeful iCa and VOCC regulation by blockers can stimulate a chondrogenic response at least in MenSCs.

Citing Articles

The study on bone marrow mesenchymal stem cell-derived extracellular matrix promoting the repair of damaged chondrocytes by regulating the Notch1/RBPJ pathway.

Huang J, Zeng N, Xu S, Lv Y, Li X, Yang P Cytotechnology. 2025; 77(1):35.

PMID: 39764424 PMC: 11700074. DOI: 10.1007/s10616-024-00702-6.


Regulation of pain neurotransmitters and chondrocytes metabolism mediated by voltage-gated ion channels: A narrative review.

Wang X, Li X Heliyon. 2023; 9(7):e17989.

PMID: 37501995 PMC: 10368852. DOI: 10.1016/j.heliyon.2023.e17989.

References
1.
Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L . Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med. 1994; 331(14):889-95. DOI: 10.1056/NEJM199410063311401. View

2.
Patergnani S, Danese A, Bouhamida E, Aguiari G, Previati M, Pinton P . Various Aspects of Calcium Signaling in the Regulation of Apoptosis, Autophagy, Cell Proliferation, and Cancer. Int J Mol Sci. 2020; 21(21). PMC: 7664196. DOI: 10.3390/ijms21218323. View

3.
Mobasheri A, van Spil W, Budd E, Uzieliene I, Bernotiene E, Bay-Jensen A . Molecular taxonomy of osteoarthritis for patient stratification, disease management and drug development: biochemical markers associated with emerging clinical phenotypes and molecular endotypes. Curr Opin Rheumatol. 2018; 31(1):80-89. DOI: 10.1097/BOR.0000000000000567. View

4.
Matas J, Orrego M, Amenabar D, Infante C, Tapia-Limonchi R, Cadiz M . Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial. Stem Cells Transl Med. 2018; 8(3):215-224. PMC: 6392367. DOI: 10.1002/sctm.18-0053. View

5.
Yoshida S, Plant S . Mechanism of release of Ca2+ from intracellular stores in response to ionomycin in oocytes of the frog Xenopus laevis. J Physiol. 1992; 458:307-18. PMC: 1175157. DOI: 10.1113/jphysiol.1992.sp019419. View